Skip to main content

Junius Daniel M

In the past year, 1 open-market sale filing worth $844.9K and no purchases.

Current role at each company

  • IDXXIDEXX Laboratories IncDirectoras of Nov 5, 2026
  • CBIOCrescent Biopharma, Inc.Directoras of May 1, 2024

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$844.9K
1 filing
Net
−$844.9K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Junius Daniel M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

IDXX IDEXX Laboratories Inc

Director5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 5, 2026 (view filing)5:01 PM ETNov 41 dayJunius Daniel MDirectorSSale−1.20K$704.07−$844.9K−33.7%2.36K after2 lots
May 14, 2025 (view filing)May 131 dayJunius Daniel MDirectorSSale−2.68K$506.41−$1.36M−44.8%3.30K after
Feb 17, 2023 (view filing)Feb 161 dayJunius Daniel MDirectorSSale−2.19K$511.68−$1.12M−42.3%2.98K after
Dec 7, 2022 (view filing)Dec 52 daysJunius Daniel MDirectorSSale−3.05K$424.91−$1.29M−50.6%2.97K after
Aug 12, 2021 (view filing)Aug 102 daysJunius Daniel MDirectorSSale−2.40K$679.58−$1.63M−45.3%2.90K after

CBIO Crescent Biopharma, Inc.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 11, 2023 (view filing)May 101 dayJunius Daniel MDirectorPPurchase+30.0K$1.56+$46.8K+47.4%93.3K after
Nov 18, 2022 (view filing)Nov 171 dayJunius Daniel MDirectorPPurchase+20.0K$1.87+$37.4K+46.2%63.3K after